Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients-Reference-Cited by-同舟云学术

Meeting report: FDA public meeting on patient-focused drug development and medication adherence in solid organ transplant patients

Published:2018-01-25 Issue:3 Volume:18 Page:564-573
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Ettenger Robert¹,Albrecht Renata²,Alloway Rita³,Belen Ozlem²,Cavaillé-Coll Marc W.²,Chisholm-Burns Marie A.⁴,Dew Mary Amanda⁵^ORCID,Fitzsimmons William E.⁶,Nickerson Peter⁷,Thompson Graham⁸,Vaidya Pujita⁸

Affiliation:

1. Department of Pediatrics; UCLA Mattel Children's Hospital; Los Angeles CA USA

2. Division of Transplant and Ophthalmology Products; Office of Antimicrobial Products; Office of New Drugs; Center for Drug Evaluation and Research; FDA; Silver Spring MD USA

3. Department of Internal Medicine; University of Cincinnati College of Medicine; Cincinnati OH USA

4. Colleges of Pharmacy and Medicine; University of Tennessee Health Science Center; Memphis TN USA

5. Departments of Psychiatry; Psychology, Epidemiology, Biostatistics, and Clinical and Translational Science; University of Pittsburgh; Pittsburgh PA USA

6. Astellas Pharma Global Development Inc; Northbrook IL USA

7. Department of Medicine; Rady Faculty of Health Sciences; University of Manitoba; Winnipeg Manitoba Canada

8. Office of Program and Strategic Analysis; Office of Strategic Programs; Center for Drug Evaluation and Research; FDA; Silver Spring MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14635/fullpdf

Reference59 articles.

1. OPTN/SRTR 2015 annual data report: Introduction;Am J Transplant,2017

2. Reg Federal. 2016 24818 24820